Intraoral photobiomodulation therapy reduced severe oral mucositis and other adverse effects of radiation therapy in patients with HNC.

Asian patients with newly diagnosed acute myeloid leukemia (AML) may have superior overall survival (OS) outcomes compared with White patients, though further data are needed to corroborate this ...

Symptom control and quality of life is improved for patients with head and neck cancer when patient-reported outcomes are monitored throughout care.

The use of a virtual reality device significantly improved depression and anxiety in patients with cancer preparing for radiotherapy.

Investigators in the phase 3 BENEFIT study evaluated MRD negativity at 12 and 24 months in patients with newly diagnosed multiple myeloma (NDMM) transplant-ineligible (TI) patients.

A recent study shows a regimen of low-dose homoharringtonine, cytarabine, and G-CSF (HAG) is an effective and promising treatment for pediatric patients with AML.

The phase 3, open-label, single arm BOND-003 trial also evaluated cretostimogene in cohort P with papillary-only high-grade NMIBC who failed prior BCG therapy.

Trastuzumab deruxtecan continues to demonstrate superior safety and efficacy compared with trastuzumab emtansine in patients with high-risk, HER2-positive early breast cancer who have residual ...

Investigators evaluated atezolizumab combined with bevacizumab and non–platinum-based chemotherapy for patients with recurrent ovarian cancer.

Medicare and Medicaid dual eligibility, higher comorbidity burden, and preexisting anxiety independently tied to greater risk.